German pharmaceutical company Stada Arzneimittel is intended to be fully acquired by either Cinven Partners and Advent International Corporation, which have both submitted bids.

“US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.”

Both companies that bid for the acquisition are based in the US.

US-based biopharmaceutical company NexImmune has been fully acquired by a consortium of private investors.

The acquisition will help NexImmune expand its portfolio in immuno-oncology and other immune-mediated disease areas.

The consortium, led by Celgene and CEOs of Medtronic, also includes other private investors.